| Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459) |
|---|
| 06/02/2009 | US7541372 Cyclopropylmethyl-{3-methoxy-4-[5-(5-methyl-3-phenyl-isoxazol-4-yl)-[1,3,4]oxadiazol-2-yl]-phenyl}-amine; -{3-Methoxy-4-[5-(5-methyl-3-phenyl-isoxazol-4-yl)-[1,3,4]oxadiazol-2-yl]-phenyl}-thiomorpholine; useful for the treatment of cognitive disorders like Alzheimer's disease |
| 05/28/2009 | WO2009066009A1 Novel 4,5-dihydroisoxazoles with estrogenic activity |
| 05/28/2009 | WO2009049180A3 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
| 05/28/2009 | WO2008152081A3 Anthelmintic benzo[d]isoxazolyl benzamide derivatives |
| 05/28/2009 | US20090137818 Crystal structure of human coronavirus 229E main proteinase and uses for developing SARS inhibitors |
| 05/28/2009 | US20090137647 Modified Macrophage Migration Inhibitory Factor Inhibitors |
| 05/28/2009 | US20090137636 Reverse Isoxazoles |
| 05/28/2009 | US20090137611 Fungicide N-Cyclopropyl-Sulfonylamide Derivatives |
| 05/28/2009 | US20090137570 Inhibitors of cathepsin s |
| 05/28/2009 | US20090136596 P38 inhibitors and methods of use thereof |
| 05/27/2009 | EP2061760A1 Benzo-fused compounds for use in treating metabolic disorders |
| 05/27/2009 | EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators |
| 05/27/2009 | EP0934287B1 Heterocyclic esters and amides |
| 05/27/2009 | CN100491355C Cyclic diamine compound having five-membered cyclic group |
| 05/26/2009 | US7538132 aryl-isoxazole-4-carbonyl-pyrrole-2-carboxylic acid amide derivatives; cognitive disorders like Alzheimer's disease; high affinity and selectivity for GABA A alpha 5 receptors; 4-[3-(4-Chloro-phenyl)-5-methyl-isoxazole-4-carbonyl]-1H-pyrrole-2-carboxylic acid prop-2-ynylamide |
| 05/26/2009 | US7538126 Crystallization in solvent dimethyl formamide; x-ray powder diffraction pattern; cyclooxygenase-2 enzyme inhibitor useful for the treatment of arthritis and pain |
| 05/26/2009 | US7538120 e.g. 7-(4-bromo-2-chlorophenylamino)-8-chloroimidazo[1,2-a]pyridine-6-carboxylic acid (2-hydroxyethoxy)-amide; mitogen-activated protein kinase inhibitor; antiproliferative, anticarcinogenic, antiinflammatory agent; rheumatoid arthritis |
| 05/26/2009 | CA2474373C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substituent on the methyl useful as bradykinin antagonists |
| 05/26/2009 | CA2344058C Diaminopropionic acid derivatives |
| 05/22/2009 | WO2009063910A1 Method for catalytic asymmetric synthesis of optically active isoxazoline compound |
| 05/21/2009 | US20090131491 ISOXAZOLE DERIVATIVE AND ISOTHIAZOLE DERIVATIVE HAVING INHIBITORY ACTIVITY ON 11(beta)-HYDROXYSTEROID DEHYDROGENASE TYPE I |
| 05/21/2009 | US20090131489 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 05/21/2009 | US20090131397 Estrogen modulators |
| 05/20/2009 | CN100488954C Aryl-substituted iso-oxazoline compounds used as bactericide |
| 05/20/2009 | CN100488506C 5-membered heterocycle derivatives, production thereof and use as medicaments |
| 05/14/2009 | WO2009061652A1 Compounds which modulate the cb2 receptor |
| 05/14/2009 | CA2704684A1 Compounds which modulate the cb2 receptor |
| 05/13/2009 | EP2057133A2 Di-amino-substituted heterocyclic compounds and methods of use |
| 05/13/2009 | EP2057116A1 New phenylsulfamoyl benzamide derivatives as bradykinin antagonists |
| 05/13/2009 | CN100486573C Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and use |
| 05/07/2009 | WO2009025983A3 Method for preparing 5-haloalkyl-4,5-dihydroisoxazole derivatives |
| 05/07/2009 | US20090118289 (Biphenyl) Carboxylic Acids and Derivatives Thereof |
| 05/06/2009 | EP1465861B1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 05/06/2009 | CN101426768A Sulfonamide compounds useful as adg receptor modulators |
| 05/06/2009 | CN101426763A Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 05/05/2009 | CA2513549C Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 04/30/2009 | WO2009055514A2 Fungicidal compounds and mixtures |
| 04/30/2009 | WO2007086076A3 An improved process for preparation of leflunomide |
| 04/30/2009 | US20090111860 Sulfonamide compounds useful as adg receptor modulators |
| 04/30/2009 | US20090111859 2-(5,5-Dimethylcyclopent-1-enyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane; metabolic disorders such as type II diabetes |
| 04/30/2009 | US20090111811 1,2,4-triazole carboxylic acid derivatives as modulators of mglur5 |
| 04/29/2009 | EP1438288B1 Substituted thioacetamides |
| 04/29/2009 | CN101421230A Novel phenyl-propargylether derivatives |
| 04/29/2009 | CN101417964A Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 04/29/2009 | CN100482666C Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics |
| 04/28/2009 | USRE40703 N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; differentiation-inducing activity, for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism, hematologic malignancy, a solid carcinoma |
| 04/28/2009 | US7524980 Vitamin D3 lactam derivative |
| 04/28/2009 | US7524969 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics |
| 04/28/2009 | US7524957 Compounds effecting glucokinase |
| 04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
| 04/28/2009 | CA2525437C Benzamide inhibitors of the p2x7 receptor |
| 04/28/2009 | CA2346396C 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 04/23/2009 | WO2009051718A2 Calcium receptor modulating agents |
| 04/23/2009 | WO2009050197A2 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
| 04/23/2009 | WO2009049846A1 Insecticidal compounds |
| 04/23/2009 | WO2009049844A1 Insecticidal compounds |
| 04/23/2009 | US20090105474 Novel anthranilic acid derivative or salt thereof |
| 04/23/2009 | CA2701792A1 Calcium receptor modulating agents |
| 04/22/2009 | EP1851193B1 Hiv protease inhibitors |
| 04/21/2009 | US7521469 E.g., (5R,8R,11S)-5-benzyl-6-hydroxy-11-(1H-indol-3-ylmethyl)-3,9-dioxo-1-phenyl-8-[(3-phenyl-5-isoxazolyl)methyl]-2-oxa-4,10-diaza-6-phosphadodecan-12-oic Acid 6-oxide; simultaneously inhibit angiotensin converting enzyme and endothelin converting enzyme; treatment of arterial hypertension |
| 04/21/2009 | US7521447 2-aza-[4.3.0]bicyclic heteroaromatic rings; useful for the treatment of inflammation, osteoarthritis, rheumatoid arthritis, psoriasis, Crohn's disease, inflammatory bowel disease, cancer, autoimmune diseases, and for the treatment of other cytokine-mediated diseases |
| 04/21/2009 | US7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 04/21/2009 | CA2182949C Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/16/2009 | WO2009049180A2 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
| 04/16/2009 | WO2009048101A1 Amide compound |
| 04/16/2009 | WO2007022529A3 Method of treating inflammatory diseases |
| 04/16/2009 | US20090099369 Process for production of 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-oxo-2-substituted-2,3-dihydro-1,2-benzisoxazol-6-yl)methoxy]phenyl]propionate ester and intermediate for the process |
| 04/16/2009 | US20090099139 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 04/16/2009 | CA2702171A1 Amide compound |
| 04/16/2009 | CA2701946A1 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
| 04/15/2009 | EP2046765A1 Insecticidal compounds |
| 04/15/2009 | EP2046764A1 Substituted isoxalines, pharmaceutical compositions containing same, methods of preparing same, and uses of same |
| 04/15/2009 | EP2046746A2 Chemical compounds |
| 04/15/2009 | CN101407500A 3,4-diaryl isoxazole-5-amido derivative, and preparation and use thereof |
| 04/15/2009 | CN101406469A Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 04/14/2009 | US7517996 methyl 3-(4-{4-[1-(2-chlorophenyl)ethoxycarbonylamino]-3-isoxazolyl}-benzylsulfanyl)propionate; compounds inhibit the physiological activity of lysophosphatidic acid (LPA); treatment of fibrosis of organs (liver, kidney, lung, and the like), hepatic disease |
| 04/14/2009 | US7517988 N-hydroxy-4-[2-(benzofuran-2-ylcarbonylamino)ethylsulfonyl]-benzamide; hepatitis C; inhibitors of histone deacetylase |
| 04/09/2009 | WO2009045999A1 Naphthalene isoxazoline compounds for control of invertebrate pests |
| 04/09/2009 | WO2009044244A2 Production of monatin enantiomers |
| 04/09/2009 | WO2009043784A1 Cyclopropyl aryl amide derivatives and uses thereof |
| 04/09/2009 | US20090093641 Synthesis of Pentafluorosulfanyl (SF5)-Substituted Heterocycles and Alkynes |
| 04/09/2009 | CA2699625A1 Cyclopropyl aryl amide derivatives and uses thereof |
| 04/08/2009 | EP2044004A2 Benzamide derivatives as modulators of 11beta-hsd1 for treating diabetes and obesity |
| 04/08/2009 | EP1430023B1 Substituied urea retinoid agonists ii |
| 04/08/2009 | CN101405277A Dicarbonylic compounds with antibacterial activity |
| 04/08/2009 | CN101405268A Amide derivatives and their application for the treatment of g protein related diseases |
| 04/08/2009 | CN100475795C Heterocyclic compounds useful as nurr-1 activators |
| 04/07/2009 | CA2462297C Method for preparing benzenesulfonyl compounds |
| 04/02/2009 | WO2009040952A1 Drug containing benzophenone derivative or its salt |
| 04/02/2009 | WO2008104994A3 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application |
| 04/02/2009 | WO2005057171A3 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds |
| 04/02/2009 | US20090087829 Production of monatin enantiomers |
| 04/01/2009 | CN101400662A Substituted isoxazoline compound and pest control agent |
| 03/31/2009 | US7511149 Using ruthenium tetraoxide and alkali metal permanganate |
| 03/31/2009 | US7511058 3-benzyl-7-(4-bromo-2-chlorophenylamino)-8-chloro-[1,2,4]triazolo [4,3-a]pyridine-6-carboxylic acid cyclopropylmethoxyamide; mitogen activated protein kinase inhibitors; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals; synergistic use |
| 03/31/2009 | US7511046 Thienoisoxazolyl- and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists |
| 03/31/2009 | US7511034 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants |
| 03/26/2009 | US20090082350 Soluble epoxide hydrolase inhibitors |
| 03/25/2009 | EP2039685A2 Heterobicyclic compounds as P38 inhibitors |
| 03/24/2009 | US7507767 Sulfonamide-containing benzene derivatives which exhibit anti-inflammatory and immunodulatory activity |